Table of Contents Table of Contents
Previous Page  228 / 238 Next Page
Information
Show Menu
Previous Page 228 / 238 Next Page
Page Background

228

29

th

CONGRESS OF THE ESPU

S3: MISCELLANEOUS

Moderators: Karen Kwak (Netherlands), Alexandra Vermandel (Belgium)

ESPU-Nurses Meeting on Thursday 12, April 2018,

14:00–14:30

14:00–14:10

S3-1 (LO)

MANAGEMENT OF KIDNEY REPLACEMENT TREATMENT

IN BLADDER EXTROPHY

Gemma FERNÁNDEZ MALDONADO, Maria MUÑOZ PÉREZ, Marta CASADO

CARRO, Esther FRANQUET BARNILS, Maria Teresa ALONSO TORRES and Sandra

PÉREZ SANCHO

Fundació Puigvert, Nurse, Barcelona, SPAIN

PURPOSE

Bladder exstrophy is a rare urogenital malformation, more often in males than females (1 to 3). For

the treatment of the disease, reconstructive care in Pediatric Urology is required. Its management

is difficult and complicated, with diverse complications, among them, the Chronic Renal Disease. It

is important to maintain the same care team in the transition stage between the pediatric and adult

age, favors the follow-up of patients and improves their quality of life. Objective: To describe clinical

characteristics, evolution and type of renal replacement therapy in patients with bladder exstrophy.

MATERIAL AND METHODS

A descriptive, retrospective, and Unicentric study in an Uropaediatrics Unit from 1980 to 2016,

in Spain. The study population were all patients diagnosed with exstrophy in renal replacement

therapy. The sample consisted of 4 patients. Sociodemographic variables, clinical care, and com-

plications were collected.

RESULTS

Four cases of bladder exstrophy were studied in renal replacement therapy. 100 % men. The

mean age of onset of CKD was 36 ± 12 years. The initial renal replacement therapy was 100 %

Hemodialysis by Venous Artery Fistula (AVF), at 3.3 ± 1.2 years of diagnosis of the disease (Range

0–5) was performed in 75 % of cases, Renal Transplant, 66, 66 % cadaver donor and 33 % live

donor.

CONCLUSIONS

Nursing professionals should provide care that promotes therapeutic education, promotion, and

prevention of complications of the disease before its occurrence and / or provide tools that contrib-

ute to Improve your quality of life.